Organotypic Modeling of the Tumor Landscape

Abstract

Cancer is a complex disease and it is now clear that not only epithelial tumor cells play a role in carcinogenesis. The tumor microenvironment is composed of non-stromal cells, including endothelial cells, adipocytes, immune and nerve cells, and a stromal compartment composed of extracellular matrix, cancer-associated fibroblasts and mesenchymal cells. Tumorigenesis is a dynamic process with constant interactions occurring between the tumor cells and their surroundings. Even though all connections have not yet been discovered, it is now known that crosstalk between actors of the microenvironment drives cancer progression. Taking into account this complexity, it is important to develop relevant models to study carcinogenesis. Conventional 2D culture models fail to represent the entire tumor microenvironment properly and the use of animal models should be decreased with respect to the 3Rs rule. To this aim, in vitro organotypic models have been significantly developed these past few years. These models have different levels of complexity and allow the study of tumor cells alone or in interaction with the microenvironment actors during the multiple stages of carcinogenesis. This review depicts recent insights into organotypic modeling of the tumor and its microenvironment all throughout cancer progression. It offers an overview of the crosstalk between epithelial cancer cells and their microenvironment during the different phases of carcinogenesis, from the early cell autonomous events to the late metastatic stages. The advantages of 3D over classical 2D or in vivo models are presented as well as the most promising organotypic models. A particular focus is made on organotypic models used for studying cancer progression, from the less complex spheroids to the more sophisticated body-on-a-chip. Last but not least, we address the potential benefits of these models in personalized medicine which is undoubtedly a domain paving the path to new hopes in terms of cancer care and cure.

Transcriptome Analysis Reveals an Inhibitory Effect of Dihydrotestosterone-Treated 2D- and 3D-Cultured Dermal Papilla Cells on Hair Follicle Growth

“…In this study, we pioneered the use of ultra-low attachment 96-well plates to convert scattered 2D structured DPCs into 3D structured multicellular spheres with a diameter of 200 µm, similar to the structure and size of dermal papillae of hair follicles in vivo. Generally, 2D cells do not have the same architecture as cells in vivo that are arranged in 3D structures unattached to planar surfaces (Haykal et al, 2020), and cells in monolayer culture proliferate at an unusually faster rate than cells in vivo (Langhans, 2018). Indeed, we confirmed a higher proliferation rate of DPCs in the 2D model than in the 3D model.…”

Identification of prognostic biomarkers associated with tumor microenvironment in ceRNA network for esophageal squamous cell carcinoma: a bioinformatics study based on TCGA database

“…In healthy tissues, stromal cells constitute the major obstacle to anti-tumor development. But transformed cancer cells can guide stromal cell reprogramming to support tumor growth and progression [ 26 ]. Furthermore, the stromal region has immunomodulatory functions, including blocking anti-tumor immunity, promoting immune escape and shaping immune cell population [ 27 , 28 ].…”

Metabolic therapy and bioenergetic analysis: The missing piece of the puzzle

“…In vivo , nonlinear microenvironmental gradients regulate the metabolic state of tumoral cells [ 263 , 264 ]. Ideally, metabolic analysis would be performed on fresh tumor samples and organotypic/organoid models [ 265 , 266 ], or with the lowest passage number [ 267 ]. In recent years, significant strides have been made to design more physiological cell culture media and to characterize the artifacts induced by an abnormal in vitro microenvironment [ [268] , [269] , [270] ].…”